Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 51 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10179912

    RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

    BIOMARIN TECHNOLOGIES B.V. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  2. US 10179142

    Treatment and/or prevention of bone metastasis

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  3. US 10173074

    Cancer stem cell vaccination and treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  4. US 10172937

    Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies

    Five Prime Therapeutics, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  5. US 10172920

    Sleep apnea treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  6. US 10167334

    Treatment of cancer using anti-TGF-BETA and PD-1 antibodies

    The Regents of the University of California · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  7. US 10167263

    Treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  8. US 10167337

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  9. US 10154974

    Use of abscisic acid for the prevention and treatment of malaria

    The Regents of the University of California · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  10. US 10155016

    Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

    Krystal Biotech, Inc. · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  11. US 10149836

    Isoxazole treatments for frontotemporal dementia

    The Board of Regents of the University of Texas System · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  12. US 10151763

    Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome

    Corcept Therapeutics Incorporated · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  13. US 10149847

    Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

    Lixte Biotechnology, Inc. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  14. US 10149829

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Dec 11, 2018 · Expires Dec 6, 2038

    granted

  15. US 10144743

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  16. US 10144726

    Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer

    SENTINEL ONCOLOGY LIMITED · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  17. US 10137130

    Methods of treatment of malignancies

    Agios Pharmaceuticals, Inc. · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  18. US 10137133

    Methods for treatment of diseases

    Galera Labs, LLC · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

  19. US 10132810

    Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor

    Nektar Therapeutics · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  20. US 10130594

    Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 20, 2018 · Expires Nov 15, 2038

    granted

  21. US 2018326059

    COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS AG [DE] · Granted Nov 15, 2018 · Expires Nov 10, 2038

    granted

  22. US 10123759

    Systems, compositions, and methods for local imaging and treatment of pain

    The Regents of the University of California · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  23. US 10117947

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  24. US 10118904

    Triazoles for the treatment of Demyelinating Diseases

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.